105 related articles for article (PubMed ID: 17295779)
1. Cimetidine inhibits epidermal growth factor-induced cell signaling.
Fujikawa T; Shiraha H; Nakanishi Y; Takaoka N; Ueda N; Suzuki M; Shiratori Y
J Gastroenterol Hepatol; 2007 Mar; 22(3):436-43. PubMed ID: 17295779
[TBL] [Abstract][Full Text] [Related]
2. Blockage of epidermal growth factor receptor by quinazoline tyrosine kinase inhibitors suppresses growth of human hepatocellular carcinoma.
Liu Y; Poon RT; Shao W; Sun X; Chen H; Kok TW; Fan ST
Cancer Lett; 2007 Apr; 248(1):32-40. PubMed ID: 16837130
[TBL] [Abstract][Full Text] [Related]
3. Crosstalk between EGFR and TrkB enhances ovarian cancer cell migration and proliferation.
Qiu L; Zhou C; Sun Y; Di W; Scheffler E; Healey S; Kouttab N; Chu W; Wan Y
Int J Oncol; 2006 Oct; 29(4):1003-11. PubMed ID: 16964397
[TBL] [Abstract][Full Text] [Related]
4. Epidermal growth factor receptor in cultured human retinal pigment epithelial cells.
Yan F; Hui YN; Li YJ; Guo CM; Meng H
Ophthalmologica; 2007; 221(4):244-50. PubMed ID: 17579290
[TBL] [Abstract][Full Text] [Related]
5. Dependence of EGF-induced increases in corneal epithelial proliferation and migration on GSK-3 inactivation.
Wang Z; Yang H; Zhang F; Pan Z; Capó-Aponte J; Reinach PS
Invest Ophthalmol Vis Sci; 2009 Oct; 50(10):4828-35. PubMed ID: 19443725
[TBL] [Abstract][Full Text] [Related]
6. Thrombin-mediated hepatocellular carcinoma cell migration: cooperative action via proteinase-activated receptors 1 and 4.
Kaufmann R; Rahn S; Pollrich K; Hertel J; Dittmar Y; Hommann M; Henklein P; Biskup C; Westermann M; Hollenberg MD; Settmacher U
J Cell Physiol; 2007 Jun; 211(3):699-707. PubMed ID: 17323377
[TBL] [Abstract][Full Text] [Related]
7. GABA-B receptor activation inhibits the in vitro migration of malignant hepatocytes.
Lodewyks C; Rodriguez J; Yan J; Lerner B; Lipschitz J; Nfon C; Rempel JD; Uhanova J; Minuk GY
Can J Physiol Pharmacol; 2011 Jun; 89(6):393-400. PubMed ID: 21762014
[TBL] [Abstract][Full Text] [Related]
8. Pamidronate induced anti-proliferative, apoptotic, and anti-migratory effects in hepatocellular carcinoma.
Wada A; Fukui K; Sawai Y; Imanaka K; Kiso S; Tamura S; Shimomura I; Hayashi N
J Hepatol; 2006 Jan; 44(1):142-50. PubMed ID: 16298452
[TBL] [Abstract][Full Text] [Related]
9. A peroxisome proliferator-activated receptor gamma antagonist induces vimentin cleavage and inhibits invasion in high-grade hepatocellular carcinoma.
Kim KR; Choi HN; Lee HJ; Baek HA; Park HS; Jang KY; Chung MJ; Moon WS
Oncol Rep; 2007 Oct; 18(4):825-32. PubMed ID: 17786342
[TBL] [Abstract][Full Text] [Related]
10. Caffeine inhibits the proliferation of liver cancer cells and activates the MEK/ERK/EGFR signalling pathway.
Okano J; Nagahara T; Matsumoto K; Murawaki Y
Basic Clin Pharmacol Toxicol; 2008 Jun; 102(6):543-51. PubMed ID: 18346049
[TBL] [Abstract][Full Text] [Related]
11. Integrin alpha1beta1 and alpha2beta1 are the key regulators of hepatocarcinoma cell invasion across the fibrotic matrix microenvironment.
Yang C; Zeisberg M; Lively JC; Nyberg P; Afdhal N; Kalluri R
Cancer Res; 2003 Dec; 63(23):8312-7. PubMed ID: 14678990
[TBL] [Abstract][Full Text] [Related]
12. Reduction of PKC alpha decreases cell proliferation, migration, and invasion of human malignant hepatocellular carcinoma.
Wu TT; Hsieh YH; Hsieh YS; Liu JY
J Cell Biochem; 2008 Jan; 103(1):9-20. PubMed ID: 17486587
[TBL] [Abstract][Full Text] [Related]
13. Curcumin attenuates EGF-induced AQP3 up-regulation and cell migration in human ovarian cancer cells.
Ji C; Cao C; Lu S; Kivlin R; Amaral A; Kouttab N; Yang H; Chu W; Bi Z; Di W; Wan Y
Cancer Chemother Pharmacol; 2008 Oct; 62(5):857-65. PubMed ID: 18214481
[TBL] [Abstract][Full Text] [Related]
14. Epidermal growth factor (EGF) induces apoptosis in a transfected cell line expressing EGF receptor on its membrane.
Zhao X; Dai W; Zhu H; Zhang Y; Cao L; Ye Q; Lei P; Shen G
Cell Biol Int; 2006 Aug; 30(8):653-8. PubMed ID: 16750403
[TBL] [Abstract][Full Text] [Related]
15. Activated hepatic stellate cells promote tumorigenicity of hepatocellular carcinoma.
Amann T; Bataille F; Spruss T; Mühlbauer M; Gäbele E; Schölmerich J; Kiefer P; Bosserhoff AK; Hellerbrand C
Cancer Sci; 2009 Apr; 100(4):646-53. PubMed ID: 19175606
[TBL] [Abstract][Full Text] [Related]
16. The role of peroxisome proliferator-activated receptor-beta/delta in epidermal growth factor-induced HaCaT cell proliferation.
Liang P; Jiang B; Yang X; Xiao X; Huang X; Long J; Zhang P; Zhang M; Xiao M; Xie T; Huang X
Exp Cell Res; 2008 Oct; 314(17):3142-51. PubMed ID: 18625220
[TBL] [Abstract][Full Text] [Related]
17. Synergistic effect between EGF and TGF-beta1 in inducing oncogenic properties of intestinal epithelial cells.
Uttamsingh S; Bao X; Nguyen KT; Bhanot M; Gong J; Chan JL; Liu F; Chu TT; Wang LH
Oncogene; 2008 Apr; 27(18):2626-34. PubMed ID: 17982486
[TBL] [Abstract][Full Text] [Related]
18. The epidermal growth factor-induced cell migration and expression of the 47,000 Mr secreted glycoprotein EIP-1 of rat liver epithelial cells are down-modulated by cyclic AMP.
Manske M; Feindler S; Bade EG
Eur J Cell Biol; 1990 Aug; 52(2):201-6. PubMed ID: 1964412
[TBL] [Abstract][Full Text] [Related]
19. Rapamycin inhibits proliferation and migration of hepatoma cells in vitro.
Shirouzu Y; Ryschich E; Salnikova O; Kerkadze V; Schmidt J; Engelmann G
J Surg Res; 2010 Apr; 159(2):705-13. PubMed ID: 19482307
[TBL] [Abstract][Full Text] [Related]
20. Mucin glycosylating enzyme GALNT2 regulates the malignant character of hepatocellular carcinoma by modifying the EGF receptor.
Wu YM; Liu CH; Hu RH; Huang MJ; Lee JJ; Chen CH; Huang J; Lai HS; Lee PH; Hsu WM; Huang HC; Huang MC
Cancer Res; 2011 Dec; 71(23):7270-9. PubMed ID: 21990321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
